Resources

59Resources found...

• Publication

  Technical And Operational Considerations For Implementing HIV Viral Load Testing

  

  This publication provides high-level guidance on implementing and scaling up HIV viral load testing programmes for health ministries and implementation partners, using a three-phased approach: (1) planning; (2) scale-up; and (3) sustainability. The guidelines for managing antiretroviral therapy (ART) issued by WHO have recognized the importance of viral load monitoring since 2003. Routine viral load monitoring is now strongly
  recommended as the monitoring strategy of choice.

   Author(s) WHO   Originally published on July 1, 2014   Posted on November 15, 2018

  ---

• Publication

  Considerations For Adoption And Use Of Multi-disease Testing Devices In Integrated Laboratory Networks

  

  Several new laboratory technologies are available or are being developed to allow for testing of different conditions using disease-specific tests on the same platform. For example, a single device may be able to test for the presence of tuberculosis (TB) and HIV, and quantitatively measure HIV and hepatitis C viral load by using disease-specific reagents or cartridges with self-contained nucleic acid testing technology. Some of these technologies are being designed for use at centralized reference laboratories while others
  may be positioned for use at or near to point of care.

   Author(s) WHO   Originally published on June 1, 2017   Posted on November 15, 2018

  ---

• Publication

  Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe

  

  Ndlovu and colleagues demonstrated the feasibility of the GeneXpert multi-disease testing at the near point of care in district and subdistrict health settings in Zimbabwe

   Author(s) Ndlovu et al   Originally published on October 2, 2024   Posted on October 12, 2018

  ---

• Publication

  Significant Patient Impact Observed Upon Implementation of Point-of-Care Early Infant Diagnosis Technologies in an Observational Study in Malawi

  

  In this Malawi study, ART initiation rates were significantly improved with the implementation of same-day POC EID testing compared with referred, longer-turnaround laboratory-based testing.

   Author(s) Mwenda et al   Originally published on October 2, 2024   Posted on October 12, 2018

  ---

• Publication

  Effect of point-of-care early infant diagnosis on antiretroviral therapy initiation and retention of patients: a cluster-randomised trial

  

  In this cluster-randomized controlled trial, Jani et al. evaluated the effect of point-of-care (POC) early infant HIV testing on rates of antiretroviral therapy (ART) initiation and retention in care among HIV-positive infants who presented for early infant diagnosis at health facilities in Mozambique. POC achieved more rapidly diagnosis and timely provision of treatment to HIV-infected infants.

   Author(s) Jani et al   Originally published on October 2, 2024   Posted on October 12, 2018

  ---

• Blog Article

  Innovative diagnostic technology can save HIV-positive infants

  

  A real life story of how of POC EID devices strategically placed at the point where they are direly needed testing for HIV exposed infants in Malawi, are great impact for the infants and their families. Infants born to or breastfed by HIV positive mothers are in need of timely HIV because risk of mortality is highest in the first weeks to months of life . Nearly half of the babies. In 2017, only 51 percent of all HIV-exposed infants were tested for HIV within the recommended first two months of life and only 52 percent of children living with HIV received life-saving ART. For details read full story here.

   Author(s) CHAI   Originally published on September 10, 2018   Posted on October 12, 2018

  ---

Filter by ticking the boxes below and then click apply

---